- Details
- Hits: 640
What’s up your Butt?? Apparently, it’s…Rectal drug use (“boofing”, “plugging” or “booty bumping” if you like?!?) is sold as a clever hack for a faster high, but it’s basically playing Russian roulette with some of the thinnest, most vulnerable tissue in your body. It can feel cleaner or “safer than injecting”, yet the mix of high‑dose drugs, fragile rectal lining and zero margin for error is exactly how people end up in, A&E’s, Eds, ICUs – or not waking up at all.
What “boofing” actually does
When you put drugs into your anus (No, not the planet you may be trying to reach virtually!) they absorb through a dense network of blood vessels and can hit your bloodstream fast, often more directly than if you’d swallowed them. But by ‘by-passing’ the digestive filters like mouth, stomach and liver, you may speed up your potential hi-hit (mainly the mouth, which alcoholics might do to negate the ‘booze breath’) yet that short-cut creates a new set of serious issues, not least being that the dose that seemed fine by mouth can be way too much rectally.
Butt Poison of Choice?
- Stimulants (cocaine, meth, “bath salts”) for a faster, harder rush.
- MDMA at festivals/parties to “make it kick in quicker”.
- Opioids (including strong synthetics) to chase euphoria without injecting.
- Alcohol or GHB/GHB‑like drugs, sometimes mixed with lube.
On the surface it can look controlled – measured dose, a clean ‘syringe barrel’, some lube – but the pharmacology underneath is absolutely not controlled. The same amount can hit you much harder than you expect, and you can’t expel it – you know “vomit it up” once it’s in – that option is gone and ipecac or stomach pumping is of no value in triage.
Why the risk of overdose explodes
Rectal use is often framed as “harm‑reduction compared with injecting”, but overdose risk usually goes up, not down. (Yet just one more example of why ‘harm reduction’ isn’t!)
Key reasons:
- Rapid absorption, tiny safety margin: The drug crosses a thin membrane and blood levels can spike quickly, faster than your brain has time to say “this is too much.”
- Oral doses don’t translate: People copy their usual pill/line dose and push it rectally; what was mild by mouth can become overwhelming via the rectum.
- Redosing trap: If the high feels “slow”, there’s a strong temptation to add more, only for both doses to kick hard together 10–20 minutes later.
With stimulants like meth or cocaine, that spike can mean arrhythmia, heart attack, stroke, seizure and extreme agitation or psychosis. With opioids, it means respiratory depression: simply not breathing deeply enough to stay alive. With alcohol or GHB, you’ve removed vomiting as an emergency safety valve, so you can slide straight from “buzzed” to unconscious, not breathing and needing resuscitation.
What it does to your body, specifically the Butt Hole
The rectum isn’t designed to be a loading dock for powders, crushed pills, crystals or concentrated alcohol (or any foreign object for that matter!) It’s thin, delicate and packed with blood vessels.
Regular or heavy rectal use can cause:
- Tears and bleeding: Small fissures from rough tips, un-dissolved particles, or just repeated irritation, which can be brutally painful and bleed.
- Ulcers, infections, abscesses: Local tissue damage becomes an opening for bacteria, leading to deep infections or pus‑filled pockets that sometimes need surgery.
- Serious structural damage: Repeated trauma can contribute to long‑term problems like incontinence or even rectal prolapse.
Because the lining is thin and highly vascular, it’s also an efficient doorway for blood‑borne infections, including HIV and hepatitis C, especially if equipment is shared or there’s any bleeding
If rectal use intersects with anal sex – before or after – you stack the risks: microscopic injuries from one activity make it easier for infections to cross during the other.
Mental health and the “how did I get here?” moment
By the time someone is boofing, they’re often not at the beginning of their spiralling dysfunctional relationship with drugs. It can signal an escalation: chasing faster, stronger effects as tolerance builds or other routes become harder or feel too embarrassing.
Rectal use doesn’t just affect your body:
- It can amplify anxiety, paranoia and mood swings, particularly with stimulants.
- It can feed into a pattern of secretive, compulsive use – hiding paraphernalia, using alone, and pushing past your own internal “this feels too far” line.
If you’ve ever had a clear, sober moment of “I can’t believe I’m doing this” around drugs and your body, that’s a signal worth listening to. We would posit that even if you don’t get that internal psycho-social alarm, the fact that you’re reading this should become that alarm… yes, you heard right, we used the word should, because it has been stolen from the protective lexicon and it needs to be put back in for your safety and well-being.
When Stupid People Don’t Want to Stop Dumb Acts?
Abstinence is always the safest option, but concerningly harm‑reduction exists precisely because people (for a number of reasons, mostly hedonic idiocy) use drugs in the real world and not in ideal conditions – Durr, ‘partying without purpose’. One damage management public health response is to emphasise reducing preventable harm but still warning people about dumb acts. Are you listening?
If someone chooses to boof despite the risks, potentially (not guaranteed) lower‑risk practices may include things like:
- Avoiding alcohol or GHB rectally entirely (the risk–reward ratio is terrible) There’s that abstinence option!
- Never guessing doses – especially with powders of unknown strength – and not matching oral doses one‑for‑one rectally. When in doubt – don’t! Hey, there’s the abstinence option, again!
- Using clean, dedicated equipment, not sharing, and not using makeshift objects that can scratch or tear.
- Leaving long gaps between doses to see the full effect before even thinking about more. Oooh! Interim abstinence at play – just keep the gap longer and longer.
- Getting regular STI and blood‑borne virus checks and using condoms/PrEP/PEP where relevant.
These strategies do not make boofing “safe” by any stretch; they just reduce some of the more predictable ways it goes very wrong.
When to seek help – immediately
Call emergency services or go to A& E or E.D if, after rectal use, anyone has:
- Trouble staying awake, very slow or strange breathing, blue lips or fingertips.
- Chest pain, palpitations, severe headache, collapse, seizure or extreme agitation/confusion.
- Severe rectal pain, heavy bleeding, fever, or a painful swelling near the anus.
You don’t have to tell staff every detail to get life‑saving care but being honest about the route and substance can help them treat you faster and more effectively.
If some part of you is already uncomfortable with how far your use has gone – or you’re supporting someone else who’s there – that discomfort is actually a healthy signal. It’s a good moment to reach out to a trusted health professional, local alcohol and other drug service, or a confidential helpline to talk through options before the next line, pill or plug pushes you past the point you can come back from.
(Source: Dalgarno Institute)
- Details
- Hits: 354
The psychedelic therapy movement has been sold to the public as a grassroots revolution driven by compassion for suffering veterans and breakthrough science. The reality is far more sinister. A coordinated campaign by Silicon Valley billionaires has hijacked the psychedelic industry, weaponising vulnerable populations whilst suppressing safety concerns that should have halted their plans years ago.
These psychedelic therapy safety concerns extend far beyond isolated incidents—they reveal systematic failures in oversight and accountability that threaten to replicate the opioid crisis under the guise of healing.
The Architect of Capture
The Psychedelic Science Funders Collaborative (PSFC) represents everything dangerous about concentrated wealth meeting unregulated pharmaceutical development. Founded in 2017, this shadowy network of approximately 200 high-net-worth individuals—including SpaceX board members, tech founders, and hedge fund managers—has systematically captured the psychedelic ecosystem. Their wealth exceeds the GDP of small countries, yet their accountability to public health standards remains virtually non-existent.
PSFC member Genevieve Jurvetson acknowledged the disproportionate power wielded by this tiny elite: “This field has been carried by like 20 families, and the leverage that they’ve had with [a] million, you know, tens of millions of dollars—hundreds of millions at this point is really quite extraordinary.”
Extraordinary indeed. Extraordinary in its concentration of control. Extraordinary in its disregard for scientific integrity. Extraordinary in its willingness to experiment on traumatised populations. (for complete expose, WRD News)
- Details
- Hits: 447
The Psychedelic Syndicate: How Silicon Valley Used Veterans to Hijack the Psychedelic Industry
Excerpt from Executive Summary
This report provides an in-depth examination of how a strategic, well-funded campaign operated to influence public perception at the expense of public health.
Psymposia has spent over a year investigating the financial and political forces shaping the psychedelic industry. Through analysis of hundreds of internal documents — including unedited emails, transcripts, presentations, and other primary materials spanning nearly a decade — this report describes the rise of the Psychedelic Science Funders Collaborative (PSFC) and its extensive influence across the field.
The prevailing media narrative has characterized the psychedelic movement as an organic coalition of grassroots activists motivated by psychedelics’ therapeutic potential. Our analysis reveals PSFC's coordinated efforts to circumvent federal regulatory structures and manipulate state-level policy development, transforming a community-led movement into a vehicle for centralized corporate influence.
Following the FDA’s 2024 rejection of MDMA-assisted therapy, PSFC-funded organizations targeted critics and whistleblowers in collaboration with the Psychedelic Communications Hub (now incorporated into the Psychedelic Safety Institute). Organizations involved in this campaign included the Multidisciplinary Association for Psychedelic Studies (MAPS), Lykos Therapeutics, and veterans groups Heroic Hearts Project and Healing Breakthrough.
Having failed to subvert the FDA regulatory process, these groups are now appealing to the Trump administration to accelerate approval based on data from clinical trials characterized by serious scientific failures. Disregarding public safety concerns in their rush to bring an experimental therapy to market, PSFC responded to the FDA's rejection by intensifying strategies that would amount to regulatory capture.
- Details
- Hits: 584
Yet more damaging evidence has emerged against psychedelic treatment, with a comprehensive meta-analysis from UCLA, Imperial College London, and UCSF revealing that magic mushrooms and other substances perform no better than traditional antidepressants.
The findings deliver another significant blow to industry advocates promoting the “psychedelics are medicine” narrative, exposing fundamental flaws in psychedelic therapy that have driven premature enthusiasm for these powerful substances.
Critical Flaws Exposed in Psychedelic Treatment
The study addresses a basic problem plaguing psychedelic therapy: researchers cannot properly “blind” participants because the obvious psychoactive effects make it clear what substance they’re receiving. This “unblinding” significantly affects statistical results and study reliability.
Recognising this endemic issue in psychedelic treatment, the authors compared results with “open-label” antidepressant trials where participants knew they were receiving specific medications.
Substantial Sample Sizes Reveal Troubling Results
The researchers examined eight psychedelic therapy studies involving nearly 550 participants alongside 16 antidepressant trials covering almost 9,800 participants. These substantial sample sizes make the results particularly concerning for advocates.
According to the pre-print: “Contrary to prior hypothesis, PAT was no more effective than open-label traditional antidepressant treatment… PAT’s lack of superiority compared to traditional antidepressants under equal-unblinding conditions highlights the influence of blinding integrity and presents a sobering viewpoint on the treatment’s potential.”
Industry Claims Undermined
This result fundamentally undermines promotional claims made by what the original researchers termed “shroom salesmen.” The evidence advocates previously cited was already problematic, plagued by small sample sizes, conflicts of interest, and methodological issues.
The new analysis suggests that apparent efficacy in psychedelic treatment stems from “unblinding” effects rather than genuine therapeutic benefits from the substances themselves.
Urgent Need to Halt Premature Implementation
These findings provide yet another compelling reason to halt efforts to fast-track these dangerous, powerful, and potentially life-altering substances into medical treatments.
The concerning results from this rigorous psychedelic therapy analysis highlight the risks of rushing experimental treatments into clinical practice without proper scientific validation.
Given the mounting evidence against efficacy claims, authorities must exercise extreme caution before approving psychedelic treatment applications for mainstream medical use, particularly given the vulnerable nature of patients seeking depression treatment.(Source: WRD News)
- Details
- Hits: 1446
A dangerous trend is sweeping through teenage communities as psilocybin teen risks escalate rapidly. Young people are treating magic mushrooms like harmless experiments, but the reality is far more sinister. These substances are triggering permanent mental illness in developing brains. The research doesn’t just suggest concern; it screams alarm about adolescent psychedelic use destroying young lives.
The Rising Trend of Youth Psychedelic Experimentation
Social media has transformed how young people discover and discuss psychedelic substances. Furthermore, the widespread promotion of magic mushrooms through trip-encouraging videos has created a dangerous misconception about their safety. Magic mushroom youth dangers are being overlooked as teenagers encounter misleading information about psilocybin’s therapeutic potential without understanding the risks.
Research confirms that the age of first psychedelic use continues to trend younger. Moreover, calls to poison control centres for adolescents who ingested mushrooms more than tripled between 2018 and 2022. This dramatic increase highlights the urgent need for awareness about psilocybin teen risks among parents, educators, and healthcare providers.
Understanding the Psychological Vulnerabilities
Adolescents face unique vulnerabilities when experimenting with psilocybin. Their developing brains are particularly susceptible to substance-induced psychological damage. Additionally, many teenagers already struggle with mental health challenges, making them especially vulnerable to magic mushroom youth dangers.
A concerning pattern involves teenagers who combine marijuana use with psilocybin experimentation. Recent evaluations reveal young people experiencing persistent dissociative symptoms, including derealisation and fleeting hallucinatory activity, even when not actively using substances. These negative residual effects demonstrate the lasting impact of psychedelic experimentation on adolescent mental health.
The Cannabis Connection and Amplified Risks
Cannabis use among young people has become increasingly normalised, yet recent research published in the Journal of the American Medical Association reveals alarming statistics. Incidents of cannabis-associated schizophrenia development jumped from 3.7% before widespread legalisation to 10.3% afterward. When combined with psilocybin use, these psilocybin teen risks may accelerate dramatically.
The combination of marijuana and magic mushrooms creates a particularly dangerous scenario for adolescents. Both substances can trigger psychotic episodes, especially in young people with genetic predispositions to mental illness. Therefore, the concurrent use of these substances represents a significant threat to youth mental health.
ADHD Medications: An Additional Risk Factor
Many teenagers diagnosed with ADHD receive stimulant medications such as Adderall. However, high doses of amphetamine-based stimulants have been linked to psychosis development. When adolescents combine prescribed stimulants with marijuana and psilocybin, the magic mushroom youth dangers multiply exponentially.
This volatile combination creates what experts describe as a “perfect storm” for psychosis development. Young people who self-medicate ADHD symptoms with marijuana whilst taking prescribed stimulants face heightened risks. Subsequently, adding psilocybin to this equation can trigger severe mental health crises.
Family History: A Critical Warning Sign
Genetic factors play a crucial role in determining susceptibility to psychotic disorders. Adolescents with family histories of mental illness face significantly elevated psilocybin teen risks when experimenting with psychedelics. Unfortunately, many young people remain unaware of their genetic vulnerabilities until serious symptoms emerge.
Parents and healthcare providers must recognise the importance of family mental health history when assessing youth substance use risks. Even carefully monitored therapeutic psilocybin use can accelerate psychosis development in genetically predisposed individuals. Therefore, recreational use among teenagers with family histories of mental illness represents an extremely dangerous gamble.
Recognising Early Warning Signs of Psilocybin Teen Risks
Healthcare professionals and parents must remain vigilant for signs of psychedelic experimentation among adolescents. Early intervention can prevent the progression to severe mental illness. Key warning signs include persistent dissociative symptoms, changes in perception, and reports of unusual sensory experiences.
The debilitating nature of psychotic illness makes early detection crucial. Young people experiencing magic mushroom youth dangers may initially dismiss symptoms as temporary effects. However, persistent psychological changes following psilocybin use require immediate professional attention.
The Misleading Safety Narrative
Media coverage of psilocybin research often emphasises potential therapeutic benefits whilst minimising risks. This creates dangerous misconceptions among young people who may view magic mushrooms as safe alternatives to other substances. However, psilocybin teen risks extend far beyond immediate physical dangers.
Researchers have documented serious concerns about recreational psilocybin use, particularly among unsupervised users. The potential for dangerous behaviour and mental illness exacerbation remains significant, especially for adolescents whose brains are still developing. These risks are amplified when young people obtain mushrooms from unregulated sources.
Educational Priorities for Prevention
Comprehensive education about psilocybin teen risks must address both immediate and long-term consequences of magic mushroom use. Young people need accurate information about genetic vulnerabilities, drug interactions, and persistent psychological effects. Educational programmes should emphasise that therapeutic research occurs under strict medical supervision with carefully screened participants.
Parents play a crucial role in prevention by maintaining open communication about substance use risks. Discussing magic mushroom youth dangers should include information about family mental health history and the importance of avoiding experimental drug use. Early conversations about these risks can prevent tragic outcomes.
The Importance of Professional Intervention
When psilocybin teen risks materialise into actual symptoms, immediate professional intervention becomes essential. Early psychosis intervention programmes offer specialised support for young people experiencing first episodes of mental illness. These programmes focus on preventing long-term disability through prompt treatment.
Healthcare providers must specifically enquire about psilocybin experimentation when evaluating adolescents with mental health concerns. Many young people may not volunteer information about magic mushroom use without direct questioning. Identifying substance use patterns early enables appropriate intervention strategies.
Protecting Young People
As discussions about psilocybin legalisation continue, protecting young people from magic mushroom youth dangers must remain a priority. The tragic consequences of adolescent psychedelic experimentation can devastate families and derail promising futures. Prevention efforts must emphasise the serious risks associated with teenage substance use.
The combination of social media influence, misleading safety narratives, and increased availability creates unprecedented challenges for youth protection. However, comprehensive education, early intervention, and professional awareness can help prevent the most serious psilocybin teen risks from becoming reality.
Understanding these dangers isn’t just about ticking boxes. It’s about stopping kids from ruining their lives. Every parent who learns about psilocybin teen risks today could prevent a teenager from developing schizophrenia tomorrow. Every teacher who spots the warning signs could save a student from permanent psychological damage.
We can’t afford to wait until these substances become more mainstream. The evidence is already clear: teenagers who experiment with magic mushrooms are gambling with their mental health, and too many are losing that bet. The choice isn’t between education and prohibition. It’s between action and tragedy.
(Source: Psychology Today)
- Drug-Related STI Prevention: Research Reveals Critical Prevention Gaps
- Australia Seizes 10 Million Vapes: World-Leading Crackdown Shows Dramatic Results in Youth Prevention
- Social Media Teen Substance Use Crisis: How Online Platforms Are Driving Youth Vaping and Cannabis Epidemic
- Drug Combinations Dangers: The Growing Crisis of Polysubstance Abuse